Post-Grant for Practitioners: Significant PTAB Decisions in BioPharma
The number of IPR petitions filed against biopharma patents at the Patent Trial and Appeal Board continues to steadily increase. Join us for a discussion on Significant PTAB Decisions in BioPharma on November 9, 2016. Fish’s Dorothy Whelan and Tasha Francis provided an update on the most recent biopharma PTAB statistics and decisions. They also discussed the implications of these decisions on the industry and the future impact on biopharma patents.
Tasha Francis, Associate
For audio-only (MP3 format), click here to launch in a new window, or right-click and choose “Save link/target as” to download to your computer.